Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold -- Update
Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, Sanofi will have the sole right to use Novavax's existing Covid-19 vaccine in combination with its own flu vaccine.
FDA Lifts Clinical Hold On Novavax COVID-19-Influenza Combo Vaccine Candidate; Stock Up
(RTTNews) - Novavax, Inc. (NVAX) Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine candidates. Novavax shares were up more than 13 percent in pre-market.
In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...
COVAX is the vaccines pillar of the Access COVID-19 Tools Accelerator ... cheaply to poorer countries. Novavax is expected to supply doses primarily to high-income countries, with SII ...
Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall and winter seasons. Here we answer common questions about the latest ...
Novavax has inked another ... The two parties initially entered into a COVID vaccine supply deal in October 2020. The U.K. originally agreed to purchase 60 million doses of the company’s ...
US biotech Novavax has begun a phase 1 study of its coronavirus vaccine ... The company has plans to produce up to 100 million vaccine doses by the end of this year, scaled up to more than ...
Don't call them boosters — they're not just another dose of last year’s protection. The coronavirus ... The Novavax ...
17d
Health officials say eligible residents can receive the COVID-19 vaccine at the same time as or at any time before or after ...
On November 1, Novavax ... initially entered into a COVID-19 vaccine supply deal in 2020, and the United Kingdom government agreed to purchase 60 million doses of its COVID-19 vaccine.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback